NBT Bank’s Ionis Pharmaceuticals IONS Stock Holding History

NBT Bank’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59K	Hold	20	–	–	﹤0.01%	912
2026 Q1	$1.5K	Buy	+20	New	+$1.58K	﹤0.01%	855
2025 Q2	–	Sell	-17,050	Closed	-$514K	–	810
2025 Q1	$514K	Hold	17,050	–	–	0.04%	265
2024 Q4	$596K	Hold	17,050	–	–	0.04%	257
2024 Q3	$683K	Hold	17,050	–	–	0.05%	248
2024 Q2	$813K	Hold	17,050	–	–	0.06%	231
2024 Q1	$739K	Hold	17,050	–	–	0.05%	230
2023 Q4	$863K	Hold	17,050	–	–	0.07%	213
2023 Q3	$773K	Buy	+17,050	New	+$703K	0.07%	185

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NBT Bank's IONS Position: Q2 2026 in Review

NBT Bank held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 20 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

NBT Bank first reported a position in IONS in Q3 2023 and has held it in 9 quarters since. The position peaked at $863K in Q4 2023. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

NBT Bank held 20 shares of Ionis Pharmaceuticals worth $1.59K as of Q2 2026.
NBT Bank left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of NBT Bank's portfolio in Q2 2026, its #912 holding.
NBT Bank first reported a position in Ionis Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
NBT Bank's Ionis Pharmaceuticals position peaked at $863K in Q4 2023.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.